Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References and Further Reading
Abbott CM, Proud CG. Translation factors: in sickness and in health. Trends Biochem Sci 2004; 29: 25–31
Alorainy IA, Patenaude YG, O’Gorman AM, Black DN, Meagher-Villemure K. Cree leukoencephalopathy: neuroimaging findings. Radiology 1999; 213: 400–406
Anzil AP, Gessaga E. Late-life cavitating dystrophy of the cerebral and cerebellar white matter. Eur Neurol 1972; 7: 79–94
Biancheri R, Rossi A, Di Rocco M, Filocamo M, Pronk JC, van der Knaap MS, Tortori-Domati P. Leukoencephalopathy with vanishing white matter: an adult onset case. Neurology 2003; 61: 1818–1819
Black DN, Booth F, Watters GV, Andermann E, Dumont C, Halliday WC, Hoogstraten J, Kabay ME, Kaplan P, Meagher-Villemure K, Michaud J, O’Gorman G. Leukoencephalopathy among native Indian infants in northern Quebec and Manitoba. Ann Neurol 1988; 24: 490–496
Blüml S, Philippart M, Schiffmann R, Seymour K, Ross BD. Membrane phospholipids and high-energy metabolites in childhood ataxia with CNS hypomyelination. Neurology 2003; 61: 648–654
Boesen T, Mohammed SS, Pavitt GD, Andersen GR. Structure of the catalytic fragment of translation initiation factor 2B and identification of a critically important catalytic residue. J Biol Chem 2004; 279: 10584–10592
Boltshauser E, Barth PG, Troost D, Martin E, Stallmach T. “Vanishing white matter” and ovarian dysgenesis in an infant with cerebro-oculo-facio-skeletal phenotype. Neuropediatrics 2002; 33: 57–62
Brück W, Herms J, Brockmann K, Schulz-Schaeffer W, Hanefeld F. Myelinopathia centralis diffusa (vanishing white matter disease): evidence of apoptotic oligodendrocyte degeneration in early lesion development. Ann Neurol 2001; 50: 532–536
Deisenhammer E, Jellinger K. Höhlenbildende Neurtralfett-leukodystrophie mit Schubverlauf. Neuropediatrics 1976; 7: 111–121
Duncan RF, Hershey JW. Protein synthesis and protein phosphorylation during heat stress, recovery, and adaptation. J Cell Biol 1989; 109: 1467–1481
Eicke WJ. Polycystische Umwandlung des Marklagers mit progredientem Verlauf. Atypische diffuse Sklerose? Arch Psychiatr Nervenkr 1962; 203: 599–602
Espay AJ, Bodensteiner JB, Patel H. Episodic coma in a new leukodystrophy. Pediatr Neurol 2002; 26: 139–142
Fogli A, Dionisi-Vici C, Deodato F, Bartuli A, Boespflug-Tanguy O, Bertini E. A severe variant of childhood ataxia with central hypomyelination / vanishing white matter leukoencephalopathy related to EIF21B5 mutation. Neurology 2002; 59: 1966–1968
Fogli A, Wong K, Eymard-Pierre E, Wenger J, Bouffard JP, Goldin E, Black DN, Boespflug-Tanguy O, Schiffmann R. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus. Ann Neurol 2002; 52: 506–510
Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O. Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 2003 72: 1544–1550
Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet 2004; 12: 561–566
Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu M-P, Rodriguez D, Boespflug-Tanguy O. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 2004; 62: 1509–1517
Francalanci P, Eymard-Pierre E, Dionisi-Vici C, Bolderini R, Piemonte F, Virgili R, Fariello G, Bosman C, Santorelli FM, Boespflug-Tanguy O, Bertini E. Fatal infantile leukodystrophy: a severe variant of CACH/VWM syndrome, allelic to chromosome 3q27. Neurology 2001; 57: 265–70
Gallo A, Rocca MA, Falini A, Scaglione C, Salvi F, Gambini A, Guerrini L, Mascalchi M, Pronk JC, van der Knaap MS, Filippi M. Multiparametric MRI in a patient with adult-onset leukoencephalopathy with vanishing white matter. Neurology 2004; 62: 323–326
Gautier JC, Gray F, Awada A, Escourolle R. Leucodystrophie orthochromatique cavitaire de l’adulte. Prolifération et inclusion oligodendrogliales. Rev Neurol 1984; 140: 493–501
Girard PF, Tommassi M, Rochet M, Boucher M. Leucoencéphalopathie avec cavitations massives, bilatérales et symétriques. Syndrome de décortication post-traumatique. Presse Med 1968; 76: 163–166
Gow A, Sharma R. The unfolded protein response in protein aggregating diseases. Neuromol Med 2003; 4: 73–94
Graveleau P, Gray F, Plas J, Graveleau J, Brion S. Leucodystrophie orthochromatique cavitaire avec modifications oligodendrogliales. Un cas sporadique adulte. Rev Neurol 1985; 141: 713–718
Hanefeld F, Holzbach U, Kruse B, Wilichowski E, Christen HJ, Frahm J. Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics 1993; 24: 244–248
Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999; 397: 271–274
Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 2000; 6: 1099–1108
Hershey JWB, Merrick WC. The pathway and mechanism of initiation of protein synthesis. In: Sonenberg N, Hershey JWB, Mathews MB, eds. Translational control of gene expression. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2000, pp 33–88
Hinnebusch AG. Mechanism and regulation of initiator methionyl-tRNA binding to ribosomes. In: Sonenberg N, Hershey JWB, Mathews MB, eds. Translational control of gene expression. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2000, pp 185–243
Kleijn M, Scheper GC, Voorma HO, Thomas AA. Regulation of translation initiation factors by signal transduction. Eur J Biochem 1998; 253: 531–544
Krishnamoorthy T, Pavitt GD, Zhang F, Dever TE, Hinnebusch AG. Tight binding of the phosphorylated alpha subunit of initiation factor 2 (eIF2alpha) to the regulatory subunits of guanine nucleotide exchange factor eIF2B is required for inhibition of translation initiation. Mol Cell Biol 2001; 21: 5018–5030
Leegwater PA, Konst AA, Kuyt B, Sandkuijl LA, Naidu S, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS. The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27. Am J Hum Genet 1999; 65: 728–734
Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 2001; 29: 383–388
Leegwater PAJ, Pronk JC, van der Knaap MS. Leukoencephalopathy with vanishing white matter: from magnetic resonance imaging pattern to five genes. J Child Neurol 2003; 18: 639–645
Li W, Wang X, van der Knaap MS, Proud CG. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Mol Cell Biol 2004; 24: 3295–3306
Matsui M, Mizutani K, Miki Y, Mezaki T, Takahashi Y, Shibasaki H. Adult-onset leukoencephalopathy with vanishing white matter. Eur J Radiol Extra 2003; 46: 90–92
Ohtake H, Shimohata T, Terajima K, Kimura T, Jo R, Kaseda R, Iizuka O, Takano M, Akaiwa Y, Goto H, Kobayashi H, Sugai T, Muratake T, Hosoki T, Shioiri T, Okamoto K, Onodera O, Tanaka K, Someya T, Nakada T, Tsuji S. Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5. Neurology 2004; 62: 1601–1603
Oldfield S, Jones BL, Tanton D, Proud CG. Use of monoclonal antibodies to study the structure and function of eukaryotic protein synthesis initiation factor eIF-2B. Eur J Biochem 1994; 221: 399–410
Prass K, Brück W, Schröder NWJ, Bender A, Prass M, Wolf T, van der Knaap MS, Zschenderlein R. Adult-onset leukoencephalopathy with vanishing white matter presenting with dementia. Ann Neurol 2001; 50: 665–668
Proud CG. Regulation of eukaryotic initiation factor eIF2B. Prog Mol Subcell Biol 2001; 26: 95–114
Proud CG. Regulation of mammalian translation factors by nutrients. Eur J Biochem 2002; 269: 5338–5349
Richardson JP, Mohammad SS, Pavitt GD. Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2b complex formation and activity. Mol Cel Biol 2004; 24: 2352–2363
Rodriguez D, Gelot A, della Gaspera B, Robain O, Ponsot G, Sarliève LL, Ghandour S, Pompidou A, Dautigny A, Aubourg P, Pham-Dinh D. Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases. Acta Neuropathol (Berl) 1999; 97: 469–480
Rosemberg S, Leite C da C, Arita FN, Kliemann SE, Lacerda MT. Leukoencephalopathy with vanishing white matter: report of four cases from three unrelated Brazilian families. Brain Dev 2002; 24: 250–256
Rowlands AG, Montine KS, Henshaw EC, Panniers R. Physiological stresses inhibit guanine-nucleotide-exchange factor in Ehrlich cells. Eur J Biochem 1988; 175: 93–99
Scheper GC, Mulder J, Kleijn M, Voorma HO, Thomas AAM, van Wijk R. Inactivation of eIF2B and phosphorylation of PHAS-I in heat-shocked rat hepatoma cells. J Biol Chem 1997; 272: 26850–26856
Schiffmann R, Moller JR, Trapp BD, Shih HH, Farrer RG, Katz DA, Alger JR, Parker CC, Hauer PE, Kaneski CR, Heiss JD, Kaye EM, Quarles RH, Brady RO, Barton NW. Childhood ataxia with diffuse central nervous system hypomyelination. Ann Neurol 1994; 35: 331–340
Schiffmann R, Tedeschi G, Kinkel P, Trapp BD, Frank JA, Kaneski CR, Brady RO, Barton NW, Nelson L, Yanovski JA. Leucodystrophy in patients with ovarian dysgenesis. Ann Neurol 1997; 41: 654–661
Schneider RJ. Translational control during heat shock. In: Sonenberg N, Hershey JWB, Mathews MB (eds) Translational Control of Gene Expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 2000, pp 581–593
Şenol U, Haspolat S, Karaali K, Lüleci E. MR imaging of vanishing white matter. AMJ Am J Roentgenol 2000; 175; 826–828
Sugiura C, Miyata H, Oka A, Takashima S, Ohama E, Takeshita K. A Japanese girl with leukoencephalopathy with vanishing white matter. Brain Dev 2001; 23: 56–61
Tedeschi G, Schiffmann R, Barton NW, Shin HH-L, Gospe SM, Brady RO, Alger JR, di Chiro G. Proton magnetic resonance spectroscopy imaging in childhood ataxia with diffuse central nervous system hypomyelination. Neurology 1995; 45: 1526–1532
Topçu I, Saatci I, Anil Apak R, Söylemezoglu F. A case of leukoencephalopathy with vanishing white matter. Neuropadiatrics 2000; 31: 100–103
van der Knaap MS, Barth PG, Gabreels FJ, Franzoni E, Begeer JH, Stroink H, Rotteveel JJ, Valk J. A new leukoencephalopathy with vanishing white matter. Neurology 1997; 48: 845–855
van der Knaap MS, Kamphorst W, Barth PG, Kraaijeveld CL, Gut E, Valk J. Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 1998; 51: 540–547
van der Knaap MS, Wevers RA, Kure S, Gabreëls FJM, Verhoeven NM, van Raaij-Selten B, Jaeken J. Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencepohalopathy with vanishing white matter. J Child Neurol 1999; 14: 728–731
van der Knaap MS, Leegwater PA, Konst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 2002; 51: 264–270
van der Knaap MS, van Berkel CGM, Herms J, van Coster R, Baethmann M, Naidu S, Boltshauser E, Willemsen MAAP, Plecko B, Hoffmann GF, Proud CG, Scheper GC, Pronk JC. eIF2B Related Disorders: Antenatal Onset and Involvement of Multiple Organs. Am J Hum Genet 2003; 73: 1199–1207
van der Knaap MS, Leegwater PAJ, van Berkel CGM, Brenner C, Storey E, di Rocco M, Salvi F, Pronk J. Arg113His mutation in eIF2B0 as cause of leukoencephalopathy in adults. Neurology 2004; 62: 1598–1600
Van Haren K, van der Voorn JP, Peterson DR, van der Knaap MS, Powers JM. The life and death of oligodendrocytes in vanishing white matter disease. J Neuropathol Exp Neurol 2004; 63: 631–640
Watanabe I, Muller J. Cavitating “diffuse sclerosis” J Neuropathol Exp Neurol 1976; 26: 437–455
Welch WJ. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol Rev 1992; 72: 1063–1081
Wong K, Armstrong RC, Gyure KA, Morrison AL, Rodriguez D, Matalon R, Johnson AB, Wollmann R, Gilbert E, Le TQ, Bradley CA, Crutchfield K, Schiffmann R. Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome. Acta Neuropathol (Berl) 2000; 100: 635–646
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2005). Leukoencephalopathy with Vanishing White Matter. In: Magnetic Resonance of Myelination and Myelin Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27660-2_65
Download citation
DOI: https://doi.org/10.1007/3-540-27660-2_65
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22286-6
Online ISBN: 978-3-540-27660-9
eBook Packages: MedicineMedicine (R0)